Page 349 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P1344 DETERMINING THE HEPATIC CYST PENETRATION OF ePOSTERS
P1345 CEFAZOLIN AND FACTORS AFFECTING PENETRATION, AN
P1346 EXPLORATIVE STUDY
Marten A. Lantinga*, Titus F. Wijnands, Rene H. te Morsche,
P1347 David M. Burger, Joost P. Drenth, The Netherlands
P1349
A RANDOMIZED, OPEN-LABEL STUDY TO EVALUATE
EFFICACY AND SAFETY OF OMBITASVIR/PARITAPREVIR/
RITONAVIR CO-ADMINISTERED WITH RIBAVIRIN IN
ADULTS WITH GENOTYPE 4 CHRONIC HEPATITIS C
INFECTION AND CIRRHOSIS
Tarik Asselah*, Tarek Hassanein, Roula B. Qaqish, Jordan J. Feld,
Christophe Hezode, Stefan Zeuzem, Peter Ferenci, Tami Pilot-Matias,
Yao Yu, Niloufar Mobashery, France

STUDY PROTOCOL FOR A PARTLY RANDOMISED, OPEN-
LABEL PHASE IIA TRIAL OF ONCE-DAILY SIMEPREVIR
COMBINED WITH SOFOSBUVIR FOR THE TREATMENT
OF HCV GENOTYPE 4-INFECTED PATIENTS WITH OR
WITHOUT CIRRHOSIS (OSIRIS)
Maissa El Raziky*, Mohamed Gamil, Radi Hammad,
Mohamed S. Hashem, Mohamed Hassany, Marwa Khairy,
Aisha El Sharkawy, Asmaa Gomaa, Sofia Keim, Gino Van Dooren,
Ralph DeMasi, Isabelle Lonjon-Domanec,Wahid Doss, Imam Waked, Egypt

A PROSPECTIVE,MULTI-CENTRIC STUDY ABOUT DISEASE
DEVELOPMENT FOR LIVER CIRRHOSIS PATIENTS
WITH ACUTE DECOMPENSATION OR NON-CIRRHOTIC
PATIENTS WITH ACUTE HEPATIC INJURY
Hai Li*, China

RANDOMISED PLACEBO-CONTROLLED TRIAL ASSESSING
WHETHER PROBIOTIC SUPPLEMENTS AMELIORATE
DEPRESSIVE SYMPTOMS IN PATIENTS WITH CHRONIC
HEPATITIS C VIRUS INFECTION
Caroline S. Stokes*, Jochen G. Schneider, Paul Wilmes, Frank Lammert,
Germany

Vienna, Austria • April 22–26, 2015 349